Page last updated: 2024-08-16

phloretin and sorafenib

phloretin has been researched along with sorafenib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdelgadir, AM; Alhaider, A; Korashy, HM; Saraswati, S; Tanwer, P	1

Other Studies

1 other study(ies) available for phloretin and sorafenib

Article	Year
Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma. Cell communication and signaling : CCS, 2019, 10-16, Volume: 17, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Mice; Molecular Docking Simulation; Phloretin; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; src Homology Domains; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2019

Article

Year

Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.

Cell communication and signaling : CCS, 2019, 10-16, Volume: 17, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Mice; Molecular Docking Simulation; Phloretin; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; src Homology Domains; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2019